克洛己新干混悬剂联合可必特及普米克令舒雾化吸入治疗小儿毛细支气管炎的疗效

Efficacy of clonazepam dry suspension combined with combitt and pulmicort respules inhalation in the treatment of bronchiolitis in children

目的:探讨克洛己新干混悬剂联合可必特及普米克令舒雾化吸入治疗小儿毛细支气管炎的疗效。方法:2019年2月-2020年2月收治毛细支气管炎患儿96例,随机分为两组,各48例,均接受基础对症治疗。对照组采用可必特及普米克令舒雾化治疗;观察组在可必特及普米克令舒雾化治疗的基础上联合克洛己新干混悬剂治疗。比较两组治疗效果。结果:观察组临床症状消失时间短于对照组,差异有统计学意义(P<0.05);观察组治疗总有效率高于对照组,差异有统计学意义(P<0.05)。结论:使用克洛己新干混悬剂联合可必特及普米克令舒雾化吸入治疗小儿毛细支气管炎疗效确切,能快速缓解患儿的相关临床症状。

Objective:To investigate the efficacy of clonazepam dry suspension combined with combitt and pulmicort respules in the treatment of bronchiolitis in children.Methods:From February 2019 to February 2020,96 children with bronchiolitis were selected,they were randomly divided into the two groups with 48 cases in each group.All patients received basic symptomatic treatment.The control group was treated with corbett and pulmicort respules.The observation group was treated with clostridium suspension combined with corbitol and pulmicort respules.The therapeutic effects of the two groups were compared.Results:The time to disappearance of clinical symptoms in the observation group were significantly shorter than those in the control group,the difference was statistically significant(P<0.05).The total effective rate of the observation group was higher than that of the control group,the difference was statistically significant(P<0.05).Conclusion:Cloxine dry suspension combined with combitt and pulmicort respules aerosol inhalation is effective in the treatment of bronchiolitis in children,and can quickly relieve the related clinical symptoms of children.